El CEO, Juan Carlos de Gregorio, lo explica en su última entrevista que ha sido publicada en El Confidencial. Recomiendan leerla para estar al día de lo último en biomedicina.
Read moreUn estudio liderado por la University of Southern California, con la participación de investigadores vinculados a la UPF y de universidades y centros de investigación de Leeds, Pittsburgh, St. Louis...
Read moreIt has been discovered that microexons are also found in another type of cell that carries out highly-specialised functions within complex tissues and organs – endocrine cells in the pancreas. Micro...
Read moreResearchers from the public and private sectors of nine European countries are partnering up for the LUCIA project (Understanding Lung Cancer-Related Risk Factors and their Impact), which seeks to imp...
Read more3P Biopharmaceuticals (3P), a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing for biological products has a 68% female wor...
Read moreThe malfunction of cellular condensates is relevant in the development of congenital malformations, common diseases, and cancer.
Read moreA study published in the Journal of Clinical Investigation Insight associates expression of the PD-1 molecule, which controls immune system responses, with slow progression of HIV infection in childre...
Read moreApTOLL is the first TLR4 antagonist neuroprotectant to achieve positive efficacy endpoints in acute ischemic stroke trials, decreasing significantly mortality and long-term functional disability
Read moreTekniker technology has applied its state-of-the-art technology and expertise to develop the professional microINR Expert coagulation meter. One of the most outstanding features of this products is it...
Read moreEl diagnóstico precoz, a través de la prueba del talón que se hace entre las primeras 24 y 72 horas de vida, es clave para ofrecer un tratamiento a los niños y aumentar la supervivencia hasta el 9...
Read moreEstán llevando a cabo el prototipo de una plataforma que, a través de la Inteligencia Artificial (IA), permitirá a los profesionales conocer mejor las características genéticas de los cánceres p...
Read moreInvestigadores de la Universidad de Bristol y el Grupo MultiMedica de Italia han desarrollado una terapia génica que mejora la función cardiaca en modelos de enfermedades cardiovasculares como la at...
Read more